News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,234 Results
Type
Article (44690)
Company Profile (321)
Press Release (694209)
Multimedia
Podcasts (97)
Webinars (17)
Section
Business (212154)
Career Advice (2108)
Deals (36455)
Drug Delivery (104)
Drug Development (82484)
Employer Resources (176)
FDA (16856)
Job Trends (15373)
News (356830)
Policy (33552)
Tag
Academia (2711)
Accelerated approval (14)
Adcomms (24)
Allergies (112)
Alliances (52621)
ALS (128)
Alzheimer's disease (1544)
Antibody-drug conjugate (ADC) (180)
Approvals (16902)
Artificial intelligence (393)
Autoimmune disease (40)
Automation (23)
Bankruptcy (366)
Best Places to Work (11931)
BIOSECURE Act (19)
Biosimilars (137)
Biotechnology (221)
Bladder cancer (113)
Brain cancer (39)
Breast cancer (415)
Cancer (3351)
Cardiovascular disease (274)
Career advice (1771)
Career pathing (33)
CAR-T (216)
CDC (39)
Cell therapy (571)
Cervical cancer (27)
Clinical research (68300)
Collaboration (1234)
Company closure (4)
Compensation (851)
Complete response letters (37)
COVID-19 (2745)
CRISPR (75)
C-suite (493)
Cystic fibrosis (126)
Data (3769)
Decentralized trials (2)
Denatured (37)
Depression (85)
Diabetes (396)
Diagnostics (6763)
Digital health (28)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (173)
Drug pricing (139)
Drug shortages (30)
Duchenne muscular dystrophy (174)
Earnings (90209)
Editorial (45)
Employer branding (22)
Employer resources (153)
Events (119691)
Executive appointments (926)
FDA (19050)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1093)
Gene editing (159)
Generative AI (32)
Gene therapy (456)
GLP-1 (862)
Government (4679)
Grass and pollen (6)
Guidances (332)
Healthcare (19579)
HIV (45)
Huntington's disease (32)
IgA nephropathy (47)
Immunology and inflammation (188)
Immuno-oncology (14)
Indications (47)
Infectious disease (2943)
Inflammatory bowel disease (166)
Inflation Reduction Act (10)
Influenza (80)
Intellectual property (167)
Interviews (326)
IPO (16952)
IRA (49)
Job creations (3828)
Job search strategy (1498)
Kidney cancer (13)
Labor market (64)
Layoffs (536)
Leadership (23)
Legal (8155)
Liver cancer (85)
Longevity (11)
Lung cancer (479)
Lymphoma (244)
Machine learning (22)
Management (62)
Manufacturing (522)
MASH (111)
Medical device (14302)
Medtech (14319)
Mergers & acquisitions (20326)
Metabolic disorders (968)
Multiple sclerosis (113)
NASH (16)
Neurodegenerative disease (159)
Neuropsychiatric disorders (37)
Neuroscience (2377)
NextGen: Class of 2025 (6849)
Non-profit (4631)
Now hiring (53)
Obesity (468)
Opinion (244)
Ovarian cancer (111)
Pain (140)
Pancreatic cancer (143)
Parkinson's disease (202)
Partnered (24)
Patents (377)
Patient recruitment (265)
Peanut (55)
People (60293)
Pharmaceutical (69)
Pharmacy benefit managers (21)
Phase I (21414)
Phase II (30061)
Phase III (22280)
Pipeline (2425)
Policy (236)
Postmarket research (2583)
Preclinical (9216)
Press Release (71)
Prostate cancer (166)
Psychedelics (39)
Radiopharmaceuticals (274)
Rare diseases (538)
Real estate (6255)
Recruiting (66)
Regulatory (23745)
Reports (51)
Research institute (2477)
Resumes & cover letters (363)
Rett syndrome (11)
RNA editing (14)
RSV (56)
Schizophrenia (110)
Series A (181)
Series B (134)
Service/supplier (15)
Sickle cell disease (72)
Special edition (20)
Spinal muscular atrophy (152)
Sponsored (35)
Startups (3860)
State (2)
Stomach cancer (14)
Supply chain (88)
Tariffs (72)
The Weekly (58)
Vaccines (900)
Venture capital (61)
Weight loss (298)
Women's health (52)
Worklife (17)
Date
Last 7 days (498)
Last 30 days (2117)
Last 365 days (31487)
2025 (22313)
2024 (36227)
2023 (41143)
2022 (52407)
2021 (56997)
2020 (55613)
2019 (48409)
2018 (36445)
2017 (33547)
2016 (33152)
2015 (39368)
2014 (32952)
2013 (28003)
2012 (30257)
2011 (30877)
2010 (28835)
Location
Africa (766)
Alabama (72)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (41196)
Australia (6840)
California (8738)
Canada (2674)
China (798)
Colorado (367)
Connecticut (381)
Delaware (237)
Europe (90344)
Florida (1289)
Georgia (298)
Hawaii (2)
Idaho (63)
Illinois (707)
India (41)
Indiana (414)
Iowa (18)
Japan (264)
Kansas (119)
Kentucky (32)
Louisiana (17)
Maine (65)
Maryland (1152)
Massachusetts (6466)
Michigan (289)
Minnesota (521)
Mississippi (4)
Missouri (109)
Montana (31)
Nebraska (25)
Nevada (100)
New Hampshire (75)
New Jersey (2381)
New Mexico (29)
New York (2369)
North Carolina (1247)
North Dakota (10)
Northern California (3941)
Ohio (268)
Oklahoma (18)
Oregon (38)
Pennsylvania (1830)
Puerto Rico (18)
Rhode Island (42)
South America (1157)
South Carolina (44)
South Dakota (1)
Southern California (3355)
Tennessee (140)
Texas (1347)
United States (31951)
Utah (262)
Virginia (214)
Washington D.C. (76)
Washington State (731)
West Virginia (4)
Wisconsin (78)
739,234 Results for "myos rens technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
September 11, 2025
·
4 min read
Press Releases
Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment
June 19, 2025
·
4 min read
Press Releases
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
September 11, 2025
·
3 min read
Press Releases
Medical Care Technologies Inc. Unveils Breakthrough AI for Early Melanoma Detection
September 18, 2025
·
1 min read
Press Releases
BioSig Technologies Inc. Announces Proposed Public Offering
August 13, 2025
·
4 min read
Policy
MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.
MYOS RENS Technology Inc. (“MYOS” or the “Company”) (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin ® , a proprietary bioactive composition derived from fertilized egg yolk that helps build lean muscle, announced that it has settled its pending litigation with RENS Technology Inc. and its president,
July 16, 2020
·
6 min read
Press Releases
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
August 13, 2025
·
4 min read
Press Releases
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025
August 15, 2025
·
8 min read
Press Releases
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
August 18, 2025
·
4 min read
Press Releases
BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer
August 20, 2025
·
5 min read
1 of 73,924
Next
